Fierce Biotech

Subscribe to Fierce Biotech feed
Updated: 3 hours 29 min ago

Fauci: Political pressure won’t interfere with FDA decisions on COVID-19 vaccines

4 hours 4 min ago
Fauci: Political pressure won’t interfere with FDA decisions on COVID-19 vaccines ntaylor Fri, 08/07/2020 - 05:17

Levo Therapeutics’ Prader-Willi med fizzles in phase 3, but company presses on

Thu, 08/06/2020 - 18:49
Levo Therapeutics’ Prader-Willi med fizzles in phase 3, but company presses on aalidrus Thu, 08/06/2020 - 21:49

Heart-mapping Acutus Medical kicks off $158M Nasdaq IPO

Thu, 08/06/2020 - 11:42
Heart-mapping Acutus Medical kicks off $158M Nasdaq IPO chale Thu, 08/06/2020 - 14:42

Biogen bets $1B+ on Denali’s anti-LRRK2 Parkinson’s program

Thu, 08/06/2020 - 07:58
Biogen bets $1B+ on Denali’s anti-LRRK2 Parkinson’s program aalidrus Thu, 08/06/2020 - 10:58

NIH launches imaging AI collaboration for COVID-19 and beyond

Thu, 08/06/2020 - 07:32
NIH launches imaging AI collaboration for COVID-19 and beyond chale Thu, 08/06/2020 - 10:32

In the face of COVID-19, cell and gene therapy space shows ‘remarkable resilience:’ report

Thu, 08/06/2020 - 05:32
In the face of COVID-19, cell and gene therapy space shows ‘remarkable resilience:’ report aalidrus Thu, 08/06/2020 - 08:32

Dicerna guides Roche-partnered hepatitis B drug past early test

Thu, 08/06/2020 - 05:10
Dicerna guides Roche-partnered hepatitis B drug past early test ntaylor Thu, 08/06/2020 - 08:10

Lundbeck’s poor run on schizophrenia trials continues as it cans midstage effort

Thu, 08/06/2020 - 03:36
Lundbeck’s poor run on schizophrenia trials continues as it cans midstage effort badams Thu, 08/06/2020 - 06:36

Novo Nordisk axes experimental obesity drugs after success with later-stage meds

Thu, 08/06/2020 - 03:04
Novo Nordisk axes experimental obesity drugs after success with later-stage meds badams Thu, 08/06/2020 - 06:04

Versant, RA Capital tee T-knife up apply TCRs to solid tumors

Thu, 08/06/2020 - 02:00
Versant, RA Capital tee T-knife up apply TCRs to solid tumors ntaylor Thu, 08/06/2020 - 05:00

Teladoc to take over Livongo in $18.5B digital health deal

Wed, 08/05/2020 - 12:31
Teladoc to take over Livongo in $18.5B digital health deal chale Wed, 08/05/2020 - 15:31

Tabletop blood tester Sight Diagnostics raises $71M to expand commercial reach

Wed, 08/05/2020 - 08:54
Tabletop blood tester Sight Diagnostics raises $71M to expand commercial reach chale Wed, 08/05/2020 - 11:54

NIH to test COVID-19 antibodies in hospitalized patients—starting with Eli Lilly’s

Wed, 08/05/2020 - 07:54
NIH to test COVID-19 antibodies in hospitalized patients—starting with Eli Lilly’s aalidrus Wed, 08/05/2020 - 10:54

Medtronic’s rechargeable neurostimulator implant nets FDA approval for bladder and bowel control

Wed, 08/05/2020 - 07:53
Medtronic’s rechargeable neurostimulator implant nets FDA approval for bladder and bowel control chale Wed, 08/05/2020 - 10:53

Taysha raises $95M to take 4 CNS gene therapies into the clinic

Wed, 08/05/2020 - 05:13
Taysha raises $95M to take 4 CNS gene therapies into the clinic ntaylor Wed, 08/05/2020 - 08:13

Fighting COVID-19 by luring the virus away from human cells with a decoy target

Wed, 08/05/2020 - 03:36
Fighting COVID-19 by luring the virus away from human cells with a decoy target aliu Wed, 08/05/2020 - 06:36

India’s Zydus starts phase 2 COVID-19 vaccine trial after clearing safety test

Wed, 08/05/2020 - 02:26
India’s Zydus starts phase 2 COVID-19 vaccine trial after clearing safety test ntaylor Wed, 08/05/2020 - 05:26

Novartis and a string of high profile backers fund next-gen Treg cell therapy startup GentiBio

Wed, 08/05/2020 - 00:58
Novartis and a string of high profile backers fund next-gen Treg cell therapy startup GentiBio badams Wed, 08/05/2020 - 03:58

Premier Research nabs Astellas, J&J cancer veteran for its oncology team

Wed, 08/05/2020 - 00:27
Premier Research nabs Astellas, J&J cancer veteran for its oncology team badams Wed, 08/05/2020 - 03:27

Versant debuts Matterhorn Biosciences with $30M to create better TCR treatments

Tue, 08/04/2020 - 20:45
Versant debuts Matterhorn Biosciences with $30M to create better TCR treatments aalidrus Tue, 08/04/2020 - 23:45